Kolexia
Masliah-Planchon Julien Pharmacien
Masliah-Planchon Julien
Pharmacien
Clcc Institut Curie
Paris, France
174 Activités
81 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Médulloblastome Tumeur rhabdoïde Carcinomes Tumeurs du cerveau Prédisposition génétique à une maladie Tumeurs du cervelet Tumeurs du sein Carcinome épidermoïde Sarcomes

Collaborateurs

Voir plus
Bourdeaut Franck
Bourdeaut Franck
Clcc Institut Curie, Paris, France
Bieche Ivan
Bieche Ivan
Institut Curie, Saint-Cloud, France
Delattre Olivier
Delattre Olivier
Clcc Institut Curie, Paris, France
Tauziede-Espariat Arnault
Tauziede-Espariat Arnault
Centre hospitalier Sainte-Anne, Paris, France

Industries

Voir plus
AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Is Primary Poorly Differentiated Sarcomatoid Malignancy of the Parotid Gland Sarcomatoid Undifferentiated/Dedifferentiated Melanoma ? Report of three unusual cases diagnosed by fine needle aspiration combined with histological, immunohistochemical and molecular analyses.
Acta cytologica   04 mars 2024
Molecular and clinical portrait of HER2-low invasive lobular carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   28 février 2024
Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.
BMC biology   20 février 2024
SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control
Essai Clinique (Institut Curie)   15 février 2024
CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Acta neuropathologica communications   19 janvier 2024
LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping.
Journal of neuropathology and experimental neurology   17 janvier 2024
Adaptive Nanopore Sequencing as a preeminent tool to elucidate structural variants in cancer predisposition genes
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Adaptive Nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Breast cancer risk in -deleted patients.
Journal of medical genetics   22 décembre 2023
BRAIN METASTASIS OF A UROTHELIAL NEUROENDOCRINE CARCINOMA: A DOUBLE PITFALL FOR NEUROPATHOLOGISTS AND DNA-METHYLATION PROFILING.
Neuropathology and applied neurobiology   20 décembre 2023